[Prevention of Rh disease by anti-D plasma. A 2-year study].
D000017:ABO Blood-Group System; D000022:Abortion, Spontaneous; D000917:Antibody Formation; D001787:Blood Group Incompatibility / Q000150:complications; D002986:Clinical Trials as Topic; D036861:Delivery, Obstetric; D004899:Erythroblastosis, Fetal / Q000150:complications / Q000517:prevention & control*; D005260:Female; D005331:Fetomaternal Transfusion / Q000150:complications; D005500:Follow-Up Studies; D006801:Humans; D007106:Immune Sera / Q000302:isolation & purification; D007116:Immunization, Passive / Q000009:adverse effects; D007518:Isoantibodies / Q000008:administration & dosage*; D008722:Methods; D010298:Parity; D011247:Pregnancy; D012204:Rh-Hr Blood-Group System
D000017:ABO Blood-Group System; D007106:Immune Sera; D007518:Isoantibodies; D012204:Rh-Hr Blood-Group System
Prophylaxie de la maladie Rh par le plasma anti-D. Deux ans d'étude